Received: 24 November 2020
Accepted: 17 February 2021
First Online: 24 February 2021
Ethics approval and consent to participate
: This study was approved by the University of Alabama at Birmingham institutional review board on September 8th, 2020 (decision number IRB-140306007).
: Not applicable.
: Dr. Reiff has nothing to disclose.Dr. Samuy has nothing to disclose.Dr. Scalici reports grants from PCORI, outside the submitted work.Dr. Mannion has nothing to disclose.Dr. Cron reports other from Pfizer, personal fees from Novartis, grants and personal fees from SOBI, outside the submitted work.